Contrariwise, the CX3CL1 membrane form in Alzheimer’s disease has a negative effect on preventing tau phagocytosis by its competition in binding the microglia receptor CX3CR1. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.